A phase IIII, randomised, observer blind, placebo controlled, multi centre, clinical trial to assess the prophylactic efficacy, safety, and immunogenicity of GSK Biologicals' herpes Zoster gE/AS01
- Schwarer, Anthony (Primary Chief Investigator (PCI))
Project: Research